Видео ютуба по тегу Dr. David S. Hong

David S. Hong, MD, regarding the Phase I clinical trial investigating sotorasib (AMG 510)
David S. Hong, MD, regarding the Phase I clinical trial investigating sotorasib (AMG 510)
Examining Sex Differences in Adolescence through the Lens of Transgender Health, David S. Hong, MD
Examining Sex Differences in Adolescence through the Lens of Transgender Health, David S. Hong, MD
HELLO KITTY + TENGE 🎀 0 - 100? #art #clay #viral #tengetenge #humour #hellokitty #diy #challenge
HELLO KITTY + TENGE 🎀 0 - 100? #art #clay #viral #tengetenge #humour #hellokitty #diy #challenge
Dr. Hong on Results of the Phase II innovaTV 201 Study
Dr. Hong on Results of the Phase II innovaTV 201 Study
Dr. David Hong Reads Gregory and his Extra X
Dr. David Hong Reads Gregory and his Extra X
David S. Hong, MD, speculates on the next steps in the development of sotorasib (AMG 510)
David S. Hong, MD, speculates on the next steps in the development of sotorasib (AMG 510)
Clinical Trials and New Drugs in the Treatment of GIST, David S. Hong, MD
Clinical Trials and New Drugs in the Treatment of GIST, David S. Hong, MD
Dr. Hong on Moving Tisotumab Vedotin to Frontline Therapy for Cervical Cancer
Dr. Hong on Moving Tisotumab Vedotin to Frontline Therapy for Cervical Cancer
JIPO Interview: Dr David Hong on Targeting KRAS: Crossroads of Signaling and Immune Inhibition
JIPO Interview: Dr David Hong on Targeting KRAS: Crossroads of Signaling and Immune Inhibition
Smashing a 34,000 Brick Statue
Smashing a 34,000 Brick Statue
Dr. David Hong on KRAS G12C Inhibitors and the Path Ahead - A Conversation with Terri Conneran
Dr. David Hong on KRAS G12C Inhibitors and the Path Ahead - A Conversation with Terri Conneran
The Grinch VS. Santa
The Grinch VS. Santa
Further TRK Inhibitor Development
Further TRK Inhibitor Development
Challenges With NGS for TRK Inhibition
Challenges With NGS for TRK Inhibition
Next-Generation Sequencing for TRK Inhibition
Next-Generation Sequencing for TRK Inhibition
Moving Forward With TRK Inhibition
Moving Forward With TRK Inhibition
Stanford Cancer Institute Breakthroughs in Cancer: David Hong, MD
Stanford Cancer Institute Breakthroughs in Cancer: David Hong, MD
Understanding Larotrectinib’s Safety Profile
Understanding Larotrectinib’s Safety Profile
Yakult Drink Popsicle #shorts
Yakult Drink Popsicle #shorts
Dr. David Hong, M.D. - Stanford University
Dr. David Hong, M.D. - Stanford University